1. Report Prologue
2.2 Scope of the Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 PORTERS Five Forces
5.3 demand & supply: gap analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 Upcoming trends
5.7.1 Market trends
5.7.2 Technological trends
5.7.3 Insurance & Regulations
6. Middle-East and Africa Pediatric healthcare Market by Type of Disease
7. Middle-East and Africa Pediatric healthcare Market by Therapeutics
8. Middle-East and Africa Pediatric healthcare Market by Treatment
9. Middle-East and Africa Pediatric healthcare Market by Region
9.2 Middle East
9.2.2 Saudi Arabia
LIST OF TABLES
TABLE 1 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY TYPE OF DISEASE
TABLE 2 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY THERAPUTICS
TABLE 3 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY TREATMENT
TABLE 4 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY REGION
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY TYPE OF DISEASE
FIGURE 4 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY THERAPUTICS
FIGURE 5 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY TREATMENT
FIGURE 6 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET BY REGION
FIGURE 7 MIDDLE-EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
Pediatric Healthcare Market is expected to grow expected to reach US$ 63.6 billion by during the forecast period at CAGR of 4.1%.the number of deaths owing to various diseases, viral infections, and malnutrition increases, which contributes to the expansion of the pediatric healthcare industry. Furthermore, the pediatric healthcare industry is fueled by growing government backing and increased research activities in technological developments. Furthermore, key players will likely launch new products for pediatric patients, increase government initiatives to raise public awareness of pediatric treatments and disorders, and improvements in healthcare infrastructure will create new opportunities for the global pediatric healthcare market over the forecast period.
Short-term disorders caused by respiratory or ocular infections are common in children. In addition to these, gastrointestinal illnesses with diarrhea and injury-related diseases are common in youngsters. These are frequently short-term disorders that pediatricians treat daily; nonetheless, treating these diseases requires a significant amount of time and financial assests from their parents and caregivers participating in primary care. Lifestyle changes have played a significant role in the rising prevalence of such diseases. While many are temporary, chronic diseases such as asthma and allergies, cerebral palsy, diabetes, obesity, and other neurological problems such as epilepsy result in chronic sickness requiring long-term therapy.
Middle East and Africa Pediatric Healthcare Market Segments:
Middle East and Africa Pediatric healthcare Market has been segmented on the basis of type of diseases which comprise Short term diseases, chronic diseases, and others. On the basis of Therapeutics which comprise cardiology, allergy and immunology, gastroenterology, infectious disease, and others. On the basis of treatment, it segmented into medication, surgery, and others
Regional Analysis of Pediatric healthcare Market:
Considering the scenario of the Middle East and Africa market, UAE region is believed to be the largest market for Middle-East and Africa Pediatric healthcare. Moreover, Saudi Arabia market is also growing and second largest market for pediatric healthcare. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Pediatric healthcare during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
Middle East and Africa Pediatric healthcare Market by Treatment
Key Players for Middle East and Africa Pediatric healthcare Market:
Some of the key players in this market are: Novartis AG (Switzerland), AstraZeneca (UK), Janssen Global Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE)
The report for Middle East and Africa Pediatric healthcare Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Study objectives of Pediatric healthcare Market:
Feb 2022 In response to a request from the US Food and Drug Administration, Pfizer Inc. and BioNTech SE announced that they had begun a rolling proposal seeking to amend the Emergency Use Permission of the Pfizer-BioNTech COVID-19 Vaccine to include children six months to four years of age in due to the increasing public health need in this population. The companies will try to finish the EUA submission in the coming days. The first two-three g doses of a proposed three-dose primary sequence in this age group are sought in this application.
|Market Size||USD 63.6 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type Of Diseases, Therapeutics and Treatment|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Novartis AG (Switzerland), AstraZeneca (UK), Janssen Global Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE)|
|Key Market Opportunities||Technological advancement and government initiatives to improve healthcare sector|
|Key Market Drivers||Increasing short term & chronic diseases|
Frequently Asked Questions (FAQ) :
Global Middle East and Africa Pediatric Healthcare Market is projected to grow at a 4.1% CAGR between 2017-2023.
The UAE is predicted to dominate Middle East and Africa Pediatric Healthcare Market.
Global Middle East and Africa Pediatric Healthcare Market is predicted to touch USD 63.6 billion by 2023.
Developing healthcare infrastructure and government initiatives to improve healthcare is boosting market growth.
Key players profiled in the Middle East and Africa Pediatric Healthcare Market include Siemens (U.S.), I-SENS, Inc. (South Korea), Abbott (U.S.), Bayer AG (Germany), Medtronic Plc. (U.S.), and Hoffmann-La Roche AG (Germany).